Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference59 articles.
1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007
2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
3. Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design;Hsu;Contemp Clin Trials,2010
4. Anatomy of the liver;Ratych,2002
5. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia;Kao;Liver Int,2005
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antioxidant and anti-HepG2 cell activities of a novel bioactive peptide from cowhide collagen in vitro;Journal of Future Foods;2024-09
2. Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by 1H NMR Based Metabolic Profiling;Journal of Proteome Research;2018-04-20
3. Ligand-decorated polysaccharide nanocarriers for targeting therapeutics to hepatocytes;Nanostructures for Cancer Therapy;2017
4. Predictors of hepatic decompensation after TACE for hepatocellular carcinoma;BMJ Open Gastroenterology;2015-12-31
5. Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival;Medicine;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3